globenewswire news

The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela

2026-09-27T13:00:00Z

The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT), a breakthrough technique combining speed and precision

Boston, Sept. 27, 2026 (GLOBE NEWSWIRE) -- Siemens Healthineers introduces Accela, the first radiotherapy system that allows for single breath-hold stereotactic treatments and enables multi-site SBRT treatment in as little as 60 seconds, significantly shortening patient time on the treatment table and the course of treatment.

Contact Info

Julie Gibson
julie.gibson@siemens-healthineers.com
+1 917-929-5779

Attachment

Accela Launch

Articles

The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela

2026-09-27T13:00:00Z

The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT), a breakthrough technique combining speed and precision

TamaBio to Showcase Synthetic Biomembrane Technology at ACS Clinical Congress 2026 in Washington, D.C.

2026-09-27T12:00:00Z

Japanese medical technology company will introduce U.S. surgeons and industry partners to its DuraBeam® and PeriBeam® devices

IBA Launches QUASAR® Penta-Guide Performance Phantom

2026-09-27T12:00:00Z

More than 25 imaging and machine QA tests in one setup.

Lanier Recovery Center launches virtual IOP for adults across Georgia

2026-09-26T14:00:00Z

Joint Commission-accredited outpatient program in Suwanee expands access to structured addiction treatment for people who can't attend in person

Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care

2026-09-25T22:54:00Z

Strategic collaboration expands no-cost access to trusted in-person and virtual mental health services, helping employers simplify care while improving affordability and access for employees and their families.

Global Health Congress 2026 Convenes Health System Leaders, Clinicians, Technologists, Investors and Innovators at the Yale Club of New York City, October 9th-11th

2026-09-25T21:49:16Z

The three-day congress features keynote speaker Robert Herjavec and a live Venture Forum where healthcare founders pitch to investors and strategic partners.

Microbot Medical® Highlights Growth Strategy

2026-09-25T21:30:00Z

User Survey Demonstrates High Satisfaction of the LIBERTY System

Family-Owned Canadian Supplement Brand Herba Ranks No. 81 on The Globe and Mail’s List of Canada’s Top Growing Companies

2026-09-25T21:19:00Z

With over 100 Canadian-made supplements, Herba earns its second consecutive appearance and ranks No. 9 in the Health Care & Wellness category.

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

2026-09-25T21:00:00Z

SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced...

Quest PharmaTech Announces Change of Chief Executive Officer

2026-09-25T21:00:00Z

EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life...

BioAge Labs to Present at Upcoming Investor Conferences

2026-09-25T20:30:00Z

EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the...

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

2026-09-25T20:30:00Z

VANCOUVER, British Columbia, Sept. 25, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and...

Crescent Biopharma Announces Grants of Inducement Awards

2026-09-25T20:15:00Z

WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...

Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

2026-09-25T17:05:00Z

Data presented at the AACR Conference on Pancreatic Cancer indicate Annamycin’s antitumor activity is partially mediated by CD8+ T cells, supporting a potential immune-mediated mechanism alongside its direct cytotoxic activity

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

2026-09-25T17:00:00Z

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel...

Orion Corporation: Acquisition of own shares during week 39, 2026

2026-09-25T16:00:00Z

Orion Corporation: Acquisition of own shares during week 39, 2026

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

2026-09-25T15:50:00Z

MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced...

Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study

2026-09-25T15:45:00Z

Ad hoc announcement pursuant to Art. 53 LR

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

2026-09-25T14:30:00Z

Leiden, the Netherlands, September 25, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has...

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

2026-09-25T13:37:47Z

MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top...

Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner

2026-09-25T13:33:56Z

SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report,...